Stay updated on Apatinib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now shown, updating the document's version. It represents a small metadata update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T09:54:08.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.3 to v3.5.4, indicating an update to the site; no study content or critical data was altered.
    Difference
    0.1%
    Check dated 2026-05-14T23:09:25.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3, replacing Revision: v3.5.2. This reflects a minor site/version update rather than any changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:41:54.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:44:00.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page content.
    Difference
    0.1%
    Check dated 2026-03-18T17:46:22.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T15:13:42.000Z thumbnail image

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.